1. Home
  2. DUOL vs ASND Comparison

DUOL vs ASND Comparison

Compare DUOL & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DUOL
  • ASND
  • Stock Information
  • Founded
  • DUOL 2011
  • ASND 2006
  • Country
  • DUOL United States
  • ASND Denmark
  • Employees
  • DUOL N/A
  • ASND N/A
  • Industry
  • DUOL Computer Software: Prepackaged Software
  • ASND Biotechnology: Pharmaceutical Preparations
  • Sector
  • DUOL Technology
  • ASND Health Care
  • Exchange
  • DUOL Nasdaq
  • ASND Nasdaq
  • Market Cap
  • DUOL 12.1B
  • ASND 7.7B
  • IPO Year
  • DUOL 2021
  • ASND 2015
  • Fundamental
  • Price
  • DUOL $306.10
  • ASND $123.00
  • Analyst Decision
  • DUOL Buy
  • ASND Strong Buy
  • Analyst Count
  • DUOL 11
  • ASND 13
  • Target Price
  • DUOL $267.56
  • ASND $195.92
  • AVG Volume (30 Days)
  • DUOL 383.7K
  • ASND 391.4K
  • Earning Date
  • DUOL 11-06-2024
  • ASND 11-05-2024
  • Dividend Yield
  • DUOL N/A
  • ASND N/A
  • EPS Growth
  • DUOL N/A
  • ASND N/A
  • EPS
  • DUOL 1.42
  • ASND N/A
  • Revenue
  • DUOL $634,489,000.00
  • ASND $340,327,869.00
  • Revenue This Year
  • DUOL $41.44
  • ASND $16.12
  • Revenue Next Year
  • DUOL $28.51
  • ASND $87.44
  • P/E Ratio
  • DUOL $207.79
  • ASND N/A
  • Revenue Growth
  • DUOL 43.42
  • ASND 166.54
  • 52 Week Low
  • DUOL $141.13
  • ASND $86.55
  • 52 Week High
  • DUOL $297.56
  • ASND $161.00
  • Technical
  • Relative Strength Index (RSI)
  • DUOL 73.00
  • ASND 39.09
  • Support Level
  • DUOL $289.53
  • ASND $124.02
  • Resistance Level
  • DUOL $296.84
  • ASND $133.97
  • Average True Range (ATR)
  • DUOL 9.25
  • ASND 3.67
  • MACD
  • DUOL -0.98
  • ASND -0.33
  • Stochastic Oscillator
  • DUOL 97.54
  • ASND 15.18

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include The Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has three predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.

Share on Social Networks: